β-Gal mRNA has been designed to produce high expression level of β-galactosidase. β-galactosidase (β-gal) mRNA, codes for a protein product of the bacterial LacZ gene. β-gal catalyses the conversion of β-galactosides into monosaccharides. It is a common marker gene used to assess transfection efficiency. OZ Biosciences mRNAs are produced by in vitro transcription and stabilized at the 5' end by modified nucleotides capping (Cap1). These mature mRNAs contain a poly(A) tail at the 3' end and are also optimized to yield improved stability and performance.

• Ready-to-use stabilised β-galactosidase mRNA
• Concentration: 1.0mg/mL in 1mM sodium citrate (pH 6.4)
• MRNA17 does not bear any additional nucleotide modifications
• MRNA14 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses
• MRNA3 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response